Safety Study of Three Formulations of the Dermal Implant ELAPR

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Skin Conditions Clinical Trial

Official title:
A Phase I Study to Assess the Safety of Three Formulations of the Dermal Implant ELAPR in Healthy Subjects

Status Completed

Clinical Trial Summary

This is a Phase I study to assess the safety of three formulations of the dermal implant ELAPR.

A Phase I study to assess the safety of three formulations of the dermal implant ELAPR in healthy subjects. ;

Allocation: Non-Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label

See also
Status	Clinical Trial	Phase
Completed	`NCT04456829` - Investigation of the Efficacies of a Resveratrol Formula on Improvement of Skin Conditions and Inflammatory Related Factors	N/A
Recruiting	`NCT06002685` - Partners in Children's Health (CSN): A Randomized Trial of an Attachment Based Intervention	N/A
Recruiting	`NCT06202274` - Clinical Study to Evaluate the Safety and Efficacy of Candela Technology	N/A
Completed	`NCT01899287` - A Randomised Clinical Trial on the Effect of Group Education on Patients With Occupational Hand Eczema	N/A